Effect of administration of apoptotic blebs on disease development in lupus mice

Autoimmunity

Volumn 45, Issue 4, 2012, Pages 290-297

  Fransen, Justin H ^a   Berden, Jo H ^a   Koeter, Claudia M ^a   Adema, Gosse J ^a   Van Der Vlag, Johan ^a   Hilbrands, Luuk B ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

apoptosis; apoptotic blebs; dendritic cells; MRL lpr mice; systemic lupus erythematosus

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; DNA ANTIBODY; HISTONE ANTIBODY; NUCLEOSOME ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY TITER; APOPTOSIS; APOPTOTIC BLEB; ARTICLE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DENDRITIC CELL; DISEASE ACTIVITY; DISEASE COURSE; FEMALE; IMMUNIZATION; LUPUS VULGARIS; MOUSE; NONHUMAN; PROTEINURIA; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, ANTINUCLEAR; APOPTOSIS; AUTOANTIBODIES; AUTOANTIGENS; DENDRITIC CELLS; DISEASE PROGRESSION; FEMALE; HISTONES; HYPERSENSITIVITY, DELAYED; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICE, INBRED CBA; MICE, INBRED MRL LPR; NUCLEOSOMES; PROTEINURIA; T-LYMPHOCYTES;

EID: 84859854088     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916934.2012.664668     Document Type: Article

References (42)

1. Gaipl US, Voll RE, Sheriff A, Franz S, Kalden JR, Herrmann M. Impaired clearance of dying cells in systemic lupus erythematosus. Autoimmun Rev 2005;4:189-194. (Pubitemid 40704701)
2. Fransen JH, Hilbrands LB, Koeter CM, Berden JHB, van der Vlag J. The role of apoptosis and removal of apoptotic cells in the genesis of systemic lupus erythematosus. Arch Med Sci 2009;5:S466-S477.
3. Savill J, Dransfield I, Gregory C, Haslett C. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat Rev Immunol 2002;2:965-975. (Pubitemid 37323217)
4. Hepburn AL, Lampert IA, Boyle JJ, Horncastle D, Ng WF, Layton M, et al. In vivo evidence for apoptosis in the bone marrow in systemic lupus erythematosus. Ann Rheum Dis 2007;66:1106-1109. (Pubitemid 47122327)
5. Herrmann M, Voll RE, Zoller OM, Hagenhofer M, Ponner BB, Kalden JR. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum 1998;41: 1241-1250. (Pubitemid 28313427)
6. Baumann I, Kolowos W, Voll RE, Manger B, Gaipl U, Neuhuber WL, et al. Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. Arthritis Rheum 2002;46: 191-201. (Pubitemid 34121664)
7. Licht R, Dieker JW, Jacobs CW, Tax WJ, Berden JH. Decreased phagocytosis of apoptotic cells in diseased SLE mice. J Autoimmun 2004;22:139-145. (Pubitemid 38252970)
8. Casciola-Rosen LA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994;179:1317-1330. (Pubitemid 24091790)
9. Dieker JW, Fransen JH, van Bavel CC, Briand JP, Jacobs CW, Muller S, et al. Apoptosis-induced acetylation of histones is pathogenic in systemic lupus erythematosus. Arthritis Rheum 2007;56:1921-1933. (Pubitemid 47110391)
10. Utz PJ, Hottelet M, Schur PH, Anderson P. Proteins phosphorylated during stress-induced apoptosis are common targets for autoantibody production in patients with systemic lupus erythematosus. J Exp Med 1997;185:843-854. (Pubitemid 27119868)
11. Casciola-Rosen L, Andrade F, Ulanet D, Wong WB, Rosen A. Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity. J Exp Med 1999;190:815-826.
12. Munoz LE, van Bavel C, Franz S, Berden J, Herrmann M, van der Vlag J. Apoptosis in the pathogenesis of systemic lupus erythematosus. Lupus 2008;17:371-375. (Pubitemid 351798710)
13. van Bavel CC, Dieker J, Muller S, Briand JP, Monestier M, Berden JH, et al. Apoptosis-associated acetylation on histone H2B is an epitope for lupus autoantibodies. Mol Immunol 2009;47:511-516.
14. van Bavel CC, Dieker JW, Kroeze Y, Tamboer WP, Voll R, Muller S, et al. Apoptosis-induced histone H3 methylation is targeted by autoantibodies in systemic lupus erythematosus. Ann Rheum Dis 2011;70:201-207.
15. Fransen JH, Hilbrands LB, Ruben J, Stoffels M, Adema GJ, van der Vlag J, et al. Mouse dendritic cells matured by ingestion of apoptotic blebs induce T cells to produce interleukin-17. Arthritis Rheum 2009;60:2304-2313.
16. Radic M, Marion T, Monestier M. Nucleosomes are exposed at the cell surface in apoptosis. J Immunol 2004;172: 6692-6700. (Pubitemid 38669105)
17. Decker P, Singh-Jasuja H, Haager S, Kotter I, Rammensee HG. Nucleosome, the main autoantigen in systemic lupus erythematosus, induces direct dendritic cell activation via a MyD88-independent pathway: consequences on inflammation. J Immunol 2005;174:3326-3334. (Pubitemid 40354036)
18. Bettelli E, Korn T, Kuchroo VK. Th17: the third member of the effector T cell trilogy. Curr Opin Immunol 2007;19: 652-657. (Pubitemid 350236805)
19. Fransen JH, van der Vlag J, Ruben J, Adema GJ, Berden JH, Hilbrands LB. The role of dendritic cells in the pathogenesis of systemic lupus erythematosus. Arthritis Res Ther 2010;12: 207.
20. Bondanza A, Zimmermann VS, Dell'Antonio G, Cin ED, Balestrieri G, Tincani A, et al. Requirement of dying cells and environmental adjuvants for the induction of autoimmunity. Arthritis Rheum 2004;50:1549-1560. (Pubitemid 38608077)
21. Bondanza A, Zimmermann VS, Dell'Antonio G, Dal Cin E, Capobianco A, Sabbadini MG, et al. Cutting edge: dissociation between autoimmune response and clinical disease after vaccination with dendritic cells. J Immunol 2003;170:24-27. (Pubitemid 36026118)
22. Ma L, Chan KW, Trendell-Smith NJ, Wu A, Tian L, Lam AC, et al. Systemic autoimmune disease induced by dendritic cells that have captured necrotic but not apoptotic cells in susceptible mouse strains. Eur J Immunol 2005;35: 3364-3375. (Pubitemid 41672540)
23. Shoshan Y, Mevorach D. Accelerated autoimmune disease in MRL/MpJ-Fas(lpr) but not in MRL/MpJ following immunization with high load of syngeneic late apoptotic cells. Autoimmunity 2004;37:103-109. (Pubitemid 38594274)
24. Georgiev M, Agle LM, Chu JL, Elkon KB, Ashany D. Mature dendritic cells readily break tolerance in normal mice but do not lead to disease expression. Arthritis Rheum 2005;52: 225-238. (Pubitemid 40129252)
25. Tzeng TC, Suen JL, Chiang BL. Dendritic cells pulsed with apoptotic cells activate self-reactive T-cells of lupus mice both in vitro and in vivo. Rheumatology (Oxford) 2006;45: 1230-1237.
26. Mevorach D, Zhou JL, Song X, Elkon KB. Systemic exposure to irradiated apoptotic cells induces autoantibody production. J Exp Med 1998;188:387-392. (Pubitemid 28357766)
27. Emmer PM, van der Vlag J, Adema GJ, Hilbrands LB. Dendritic cells activated by lipopolysaccharide after dexamethasone treatment induce donor-specific allograft hyporesponsiveness. Transplantation 2006;81:1451-1459. (Pubitemid 43852991)
28. Greenberger JS, Sakakeeny MA, Humphries RK, Eaves CJ, Eckner RJ. Demonstration of permanent factor-dependent multipotential (erythroid/ neutrophil/basophil) hematopoietic progenitor cell lines. Proc Natl Acad Sci USA 1983;80: 2931-2935. (Pubitemid 13104151)
29. Guchhait P, Tosi MF, Smith CW, Chakaraborty A. The murine myeloid cell line 32Dcl3 as a model system for studying neutrophil functions. J Immunol Meth 2003;283: 195-204. (Pubitemid 37501070)
30. Fransen JH, Hilbrands LB, Jacobs CW, Adema GJ, Berden JH, Van der Vlag J. Both early and late apoptotic blebs are taken up by DC and induce IL-6 production. Autoimmunity 2009; 42:325-327.
31. van Bruggen MC, Walgreen B, Rijke TP, Corsius MJ, Assmann KJ, Smeenk RJ, et al. Heparin and heparinoids prevent the binding of immune complexes containing nucleosomal antigens to the GBM and delay nephritis in MRL/lpr mice. Kidney Int 1996;50:1555-1564. (Pubitemid 26364261)
32. Dieker JW, Sun YJ, Jacobs CW, Putterman C, Monestier M, Muller S, et al. Mimotopes for lupus-derived anti-DNA and nucleosome-specific autoantibodies selected from random peptide phage display libraries: facts and follies. J Immunol Meth 2005;296:83-93. (Pubitemid 40174742)
33. Mukundan L, Odegaard JI, Morel CR, Heredia JE, Mwangi JW, Ricardo-Gonzalez RR, et al. PPAR-delta senses and orchestrates clearance of apoptotic cells to promote tolerance. Nat Med 2009;15:1266-1272.
34. A-Gonzalez N, Bensinger SJ, Hong C, Beceiro S, Bradley MN, Zelcer N, et al. Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR. Immunity 2009;31:245-258.
35. Sauter B, Albert ML, Francisco L, Larsson M, Somersan S, Bhardwaj N. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J Exp Med 2000;191:423-434.
36. Demaria S, Santori FR, Ng B, Liebes L, Formenti SC, Vukmanovic S. Select forms of tumor cell apoptosis induce dendritic cell maturation. J Leukoc Biol 2005;77:361-368. (Pubitemid 40289566)
37. Tesniere A, Apetoh L, Ghiringhelli F, Joza N, Panaretakis T, Kepp O, et al. Immunogenic cancer cell death: a key-lock paradigm. Curr Opin Immunol 2008;20:504-511.
38. Zhang QH, Link H, Xiao BG. Efficacy of peripheral tolerance induced by dendritic cells is dependent on route of delivery. J Autoimmun 2004;23:37-43. (Pubitemid 38953791)
39. Verdijk P, Aarntzen EH, Punt CJ, de Vries IJ, Figdor CG. Maximizing dendritic cell migration in cancer immunotherapy. Expert Opin Biol Ther 2008;8:865-874. (Pubitemid 352006999)
40. Eggert AA, Schreurs MW, Boerman OC, Oyen WJ, de Boer AJ, Punt CJ, et al. Biodistribution and vaccine efficiency of murine dendritic cells are dependent on the route of administration. Cancer Res 1999;59:3340-3345. (Pubitemid 29334488)
41. Lappin MB, Weiss JM, Delattre V, Mai B, Dittmar H, Maier C, et al. Analysis of mouse dendritic cell migration in vivo upon subcutaneous and intravenous injection. Immunology 1999; 98:181-188. (Pubitemid 29487638)
42. Huck SP, Tang SC, Andrew KA, Yang J, Harper JL, Ronchese F. Activation and route of administration both determine the ability of bone marrow-derived dendritic cells to accumulate in secondary lymphoid organs and prime CD8+ T cells against tumors. Cancer Immunol Immunother 2008;57:63-71. (Pubitemid 350043649)